The sensitivity of SAOS-LM5 CKB KO cells to cisplatin (CDDP), doxorubicin (DOX) and methotrexate (MTX), drugs commonly used in OSA therapy [23], was also not altered (Fig. 2f). This evidence concerns the gene CKB and obstructive sleep apnea syndrome.